Generic transplant drugs as good as brand name, experts say
Scientists have found that generic formulations of tacrolimus, a drug used post-transplant to lower the risk of organ rejection, are just as good as the name-brand version. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 3, 2015 Category: Science Source Type: news
Study: Generic transplant drugs as good as brand name
(University of Cincinnati Academic Health Center) A University of Cincinnati-led research team has found that generic formulations of tacrolimus, a drug used post-transplant to lower the risk of organ rejection, are just as good as the name-brand version. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2015 Category: Global & Universal Source Type: news
Selten Pharma, Inc. Receives Orphan Drug Designation From U.S. FDA for the Treatment of Pulmonary Arterial Hypertension
SARATOGA, Calif., March 18, 2015 -- (Healthcare Sales & Marketing Network) -- Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced tod... Biopharmaceuticals, FDASelten Pharma, tacrolimus, pulmonary arterial hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 18, 2015 Category: Pharmaceuticals Source Type: news
tacrolimus, Prograf, Astagraf XL, Hectoria
Title: tacrolimus, Prograf, Astagraf XL, HectoriaCategory: MedicationsCreated: 12/6/1998 12:00:00 AMLast Editorial Review: 2/17/2015 12:00:00 AM (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - February 17, 2015 Category: Gastroenterology Source Type: news
Tacrolimus Similar to MMF as Induction for Lupus NephritisTacrolimus Similar to MMF as Induction for Lupus Nephritis
In combination with steroids, tacrolimus (TAC) seems to have similar efficacy and safety as mycophenolate mofetil (MMF) as induction therapy for lupus nephritis, researchers reported December 30 in Annals of the Rheumatic Diseases Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2015 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Tacrolimus for Induction in Lupus Nephritis? (CME/CE)
(MedPage Today) -- Patients did just as well with tacrolimus as with mycophenolate mofetil. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 8, 2015 Category: Rheumatology Source Type: news
Prograf Aids in Myopathy-Related Lung Disease
(MedPage Today) -- Study "provides some reassurance" on use of tacrolimus. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 30, 2014 Category: Primary Care Source Type: news
Maintenance tacrolimus for eczema boosts quality of life
AMSTERDAM – Twice-weekly proactive maintenance therapy with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis resulted in dramatic improvement in self-reported quality of life in a 12-month observational study.
This prospective study was designed to assess patients’ own...googletag.display('div-gpt-ad-cta'); (Source: Skin and Allergy News)
Source: Skin and Allergy News - December 15, 2014 Category: Dermatology Tags: FPN News FPN Dermatology IMN News IMN Dermatology SAN Clinical News SAN News SAN Atopic Dermatitis European Academy of Dermatology and Venereology Source Type: news
Lupus Nephritis: Multidrug Induction Ups Complete Responses Lupus Nephritis: Multidrug Induction Ups Complete Responses
A combination of tacrolimus, mycophenolate mofetil, and steroid resulted in higher remission rates than cyclophosphamide plus steroid. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2014 Category: Consumer Health News Tags: Nephrology News Source Type: news
Underused Drug Combo May Up Survival in Lung Transplant
No antibody induction therapy with sirolimus plus tacrolimus associated with maximal survival (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Pharmacy, Pulmonology, Surgery, Journal, Source Type: news
Strides Arcolab gets USFDA approval for Tacrolimus capsules
The product will be manufactured at the company's oral dosage facility at Bangalore and marketed directly by Strides in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2014 Category: Pharmaceuticals Source Type: news
Topical Tacrolimus 0.03% in Vernal KeratoconjunctivitisTopical Tacrolimus 0.03% in Vernal Keratoconjunctivitis
This study compares the efficacy of this agent when used alone or combined with olopatadine. Eye & Contact Lens (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2014 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news
Veloxis Announces Scientific Publication of Phase II Study Demonstrating Conversion from Twice-Daily Tacrolimus to Once-Daily Envarsus® in Liver Transplant Patients
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - April 28, 2014 Category: Pharmaceuticals Source Type: news
Tacrolimus Eye Drops for Refractory Allergic Ocular DiseasesTacrolimus Eye Drops for Refractory Allergic Ocular Diseases
Use of tacrolimus 0.1% eye drops is associated with significant improvement of refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement, according to an observational study from Japan. Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - April 22, 2014 Category: Opthalmology Tags: Ophthalmology News Source Type: news
FDA awards $2.25M grant to study immunosuppresive drug in high-risk patients
(University of Cincinnati Academic Health Center) University of Cincinnati Research Professor Rita Alloway, PharmD, has been awarded a $2.25 million grant from the U.S. Food and Drug Administration to study the safety and efficacy of the generic immunosuppressive drug tacrolimus in transplant patients. As a "cornerstone drug" in post-transplant immunosuppression, tacrolimus is used to lower the risk of organ rejection -- these studies are aimed to address public concerns regarding the use of new generic formulations in high-risk transplant recipients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2013 Category: Global & Universal Source Type: news
